Baron R, Levine J D, Fields H L
Department of Neurology, University of California at San Francisco, USA.
Muscle Nerve. 1999 Jun;22(6):678-95. doi: 10.1002/(sici)1097-4598(199906)22:6<678::aid-mus4>3.0.co;2-p.
The striking response of causalgia and reflex sympathetic dystrophy (RSD) to sympatholytic procedures together with signs of autonomic nervous system abnormalities suggest that the sympathetic efferent system can generate or enhance pain (sympathetically maintained pain, SMP). This concept is supported by human and animal experiments indicating that sympathetic activity and catecholamines can activate primary afferent nociceptors. Some clinical evidence, however, calls the SMP concept into question and alternative explanations have been advanced. In this review, we describe the clinical features of causalgia and RSD and the evidence for sympatholytic efficacy. The major barrier to proving the SMP concept is that all available sympatholytic procedures are problematic. We conclude that, although the weight of current evidence supports the SMP concept and its relevance to causalgia and RSD, it remains unproven by scientific criteria. More careful adherence to diagnostic criteria and well-controlled trials of sympatholysis are needed to finally settle the issue.
灼性神经痛和反射性交感神经营养不良(RSD)对交感神经阻滞术的显著反应,以及自主神经系统异常的体征表明,交感传出系统可产生或增强疼痛(交感神经维持性疼痛,SMP)。这一概念得到了人体和动物实验的支持,这些实验表明交感神经活动和儿茶酚胺可激活初级传入伤害感受器。然而,一些临床证据对SMP概念提出了质疑,并提出了其他解释。在本综述中,我们描述了灼性神经痛和RSD的临床特征以及交感神经阻滞术疗效的证据。证明SMP概念的主要障碍在于,所有可用的交感神经阻滞术都存在问题。我们得出结论,尽管目前的证据支持SMP概念及其与灼性神经痛和RSD的相关性,但从科学标准来看,它仍未得到证实。需要更严格地遵守诊断标准,并进行严格控制的交感神经阻滞试验,以最终解决这个问题。